Phase 2 trial of two courses of cyclophosphamide and etoposide for relapsed high-risk osteosarcoma patients (Cancer (2009) 115, (2980-2987))

M. Berger, G. Grignani, S. Ferrari, E. Biasin, A. Brach Del Prever, S. Aliberti, F. Saglio, M. Aglietta, F. Fagioli

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)5126
Number of pages1
JournalCancer
Volume115
Issue number21
DOIs
Publication statusPublished - Nov 1 2009

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this